HOME >> BIOLOGY >> NEWS
Mouse brain stem cells capable of converting into blood vessel cells

Adult stem cells in the brains of mice possess a broader differentiation potential than previously thought and may be capable of developing into other cell types including those involved in the formation of new blood vessels, according to a new study supported by the National Institute on Aging (NIA), a part of the National Institutes of Health. The finding could help resolve a critical question about these promising, but still mystifying cells.

The report by Fred H. Gage, Ph.D., and colleagues at the Salk Institute in La Jolla, CA, and Kumamoto University in Japan, appears in the July 15, 2004, issue of Nature.

Adult stem cells in the brain were proposed to be restricted to the generation of neurons and cells, such as glial cells, that support neuron function. Experiments over the past several years have raised the possibility that stem cells from the brain may be able to give rise to additional cell types, a phenomenon known as plasticity. But recent findings have challenged this theory, suggesting that many of these stem cells merely merge or "fuse" with an existing cell within a tissue forming a hybrid that takes on the pre-existing cell's functions.

"Resolving this issue is important because fused cells may have a different therapeutic potential than stem cells that differentiate into new cells, says Bradley C. Wise, Ph.D., of the NIA's Neuroscience and Neuropsychology of Aging Program. "While this new finding doesn't fully answer this vital question, it keeps open the possibility that adult stem cells from different organs one day may be harnessed to help prevent and treat neurological disorders."

In their experiments, Gage and his colleagues grew mouse brain stem cells, which form neurons and glial cells, in the same culture dishes with human endothelial cells, which form the lining of blood vessels. Over time, about 6 percent of the mouse neural stem cells began to show signs that they had developed into cells similar to endot
'"/>

Contact: Doug Dollemore
dollemod@nia.nih.gov
301-496-1752
NIH/National Institute on Aging
14-Jul-2004


Page: 1 2

Related biology news :

1. Half-million dollar landmark achieved for the Methuselah Mouse Prize
2. Mouse study shows NPAS3 and NPAS1 genes may be linked to psychosis
3. Mouse study yields clue to why liver is less prone to rejection, say Pitt researchers
4. Mouse embryonic germ cells and male gametes created in the lab
5. Mouse, stripped of a key gene, resists diabetes
6. Mouse model of schizophrenia could speed identification of new antipsychotic drugs
7. Mouse study identifies protective mechanism against alcohol-induced embryo toxicity
8. Mouse model offers new explanation for kidney disease and failure
9. Mouse study suggests mammoth evolutionary change
10. Mouse genetic model for spongiform brain diseases
11. Mouse model links alcohol intake to marijuana-like brain compounds

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mouse brain stem cells capable converting into blood vessel cells

(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
(Date:5/8/2015)... -- Synaptics Inc. (NASDAQ: SYNA ), the leading developer ... executive management team will present at the following investor events: ... Conference Date: May 18, 2015 Time: 10:40am ET ... Cowen and Company Technology, Media & Telecom ... New York Palace Hotel, New York, NY ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/27/2015)... May 27, 2015 RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... it has commenced a public offering of shares ... of its common stock and overallotment purchase rights ... shares of common stock, warrants and overallotment purchase ...
(Date:5/27/2015)... , May 26, 2015 Research and ... the "Global Breast Cancer Monoclonal Antibodies Market ... Globally, Roche seems to dominate the breast ... Its block buster molecule, Herceptin has been able ... was found that breast cancer cells become recalcitrant ...
(Date:5/27/2015)... 27, 2015 Expanding in a big ... Avalon Biomed Inc. recently inked a deal ... Dental Co. Ltd. , the largest endodontic distributor in ... international market for Avalon Biomed, which manufactures Grey MTA ... silicate-based dental cements that have won renown from dentists ...
(Date:5/27/2015)... , May 27, 2015  Tikcro Technologies Ltd. (OTCQB: ... March 31, 2015. Aviv Boim ... continued pre-clinical work to generate functional specific antibodies, targeting ... stage, we are encouraged by the development progress. We ... new antibodies which modulate immune checkpoints gain clinical acceptance ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3
Cached News: